CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,528,710 | -73.3% | 254,361 | -74.1% | 0.44% | -77.4% |
| Q3 2022 | $5,724,000 | -30.5% | 983,516 | -28.7% | 1.94% | -23.7% |
| Q2 2022 | $8,239,000 | -21.6% | 1,380,111 | -38.7% | 2.54% | -41.7% |
| Q1 2022 | $10,508,000 | +185.5% | 2,250,000 | +51.6% | 4.35% | +191.6% |
| Q4 2021 | $3,680,000 | – | 1,483,829 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|